X0609 4 2026-10-16 0 0001635088 Roivant Sciences Ltd. ROIV 0001750094 Gline Matthew true C/O ROIVANT SCIENCES LTD. 7TH FLOOR, 50 BROADWAY LONDON X0 SW1H 0DB UNITED KINGDOM 1 1 0 0 CEO 0 Common Shares 2026-10-16 4 F 0 34638 33.53 D 16549136 D Represents the "net settlement" by the Issuer of performance restricted stock units ("PSUs"), previously granted to the reporting person on July 26, 2024, in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of a portion of such PSUs following the achievement of both the performance-based vesting conditions (the "Performance Condition") and service-based vesting conditions (the "Service Condition") applicable to such PSUs. Additional PSUs that have satisfied both the Performance Condition and the Service Condition will be settled in one or more future instalments in accordance with their terms. The Common Shares issued on settlement of the PSUs (excluding those withheld for tax withholding obligations, as described above) remain subject to a two-year holding period before such Common Shares may be sold, measured from the date the Service Condition of the PSUs is satisfied. By: /s/ Sam Kaplan, as Attorney-in-Fact for Matthew Gline 2026-10-20